EDGAR Filing Documents for 0001213900-22-002888

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001213900-22-002888

Filing Date

2022-01-21

Accepted

2022-01-20 19:17:54

Documents

Period of Report

2022-01-20

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN PRIVATE ISSUER	ea154280-6k_chinasxtphar.htm	6-K	21212
2	UNDERWRITING AGREEMENT BY AND BETWEEN CHINA SXT PHARMACEUTICALS, INC. AND AEGIS	ea154280ex1-1_chinasxtphar.htm	EX-1.1	246762
3	FORM OF WARRANT AGENT AGREEMENT (INCLUDING THE FORM OF PRE-FUNDED WARRANT)	ea154280ex4-1_chinasxtphar.htm	EX-4.1	177500
4	OPINION OF CAMPBELLS LEGAL (BVI) LIMITED	ea154280ex5-1_chinasxtphar.htm	EX-5.1	44450
5	OPINION OF HUNTER TAUBMAN FISCHER & LI LLC	ea154280ex5-2_chinasxtphar.htm	EX-5.2	13531
6	PRESS RELEASE TITLED: "CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES PROPOSED UNDERW	ea154280ex99-1_chinasxtphar.htm	EX-99.1	9957
7	PRESS RELEASE TITLED: "CHINA SXT PHARMACEUTICALS, INC. PRICES $3.5 MILLION UNDER	ea154280ex99-2_chinasxtphar.htm	EX-99.2	13541
8	PRESS RELEASE TITLED: "CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES SUCCESSFUL CLOS	ea154280ex99-3_chinasxtphar.htm	EX-99.3	10265
9	GRAPHIC	ex5-1_001.jpg	GRAPHIC	12581
10	GRAPHIC	ex5-2_001.jpg	GRAPHIC	6844
11	GRAPHIC	ex5-2_002.jpg	GRAPHIC	2533
12	GRAPHIC	ex99-1_001.jpg	GRAPHIC	9503
13	GRAPHIC	ex99-2_001.jpg	GRAPHIC	9503
14	GRAPHIC	ex99-3_001.jpg	GRAPHIC	9501
	Complete submission text file	0001213900-22-002888.txt		608559

Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300

Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290

China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)